Product Design
The Fallacy of Non-Tobacco Cigarets
Abstract
Discusses the smoking and health controversy and the current competition the tobacco industry is facing from companies in other industries who are researching and marketing synthetic, non-tobacco cigarettes. Challenges the safety and effectiveness of the materials being used in non-tobacco cigarettes. Queries as to whether these new cigarettes are any safer than tobacco cigarettes, noting that they "'present unknown and possibly entirely new potential hazards.'" Notes that a non-tobacco cigarette may very well be "the hoax of the century."
Fields
- Hypothesis
- Health effectsDesign changes which have measurably altered health effects of cigarette smoke, both for smokers and nonsmokers.
- Introduction of new/unconventional productsResearch and development of novel nicotine delivery devices and experimental tobacco designs.
- Low-yield cigarettesModification of low yield products to assure that adequate levels of nicotine delivery are maintained, and effects of yield changes on toxicity and dependence.
- Keyword
- Low delivery (Reduced delivery)
- Nicotine delivery (Smoke nicotine or nicotine yield)
- Smoking and Health
- Smoking and Health Controversy
- Smoke Constituent
- Nicotine
- Named Organization
- Bayer
- Celanese Corporation (Sold materials for cigarette filters)sold materials for cigarette filters
- Chemistry in Britain
- Courtaulds
- Federal Trade Commission (Enforcement agency for laws against deceptive advertising)Enforces laws against false and deceptive advertising, including ads for tobacco products. Ensures proper display of health warnings in ads and on tobacco products;collects and reports to Congress information concerning cigarette and smokeless tobacco advertising, sales expenditures, and the tar, nicotine, and carbon monoxide content of cigarettes.
- Hunter Committee (British committee investigating tobacco issues)
- ICI
- Subject
- anti-smoking advocacy
- tar level
Document Images
; ? <?J . r ~ .. ~ R. ... :.. . ^ .. ..._ . .. .. . .. - r_.. ,.
^' al chem ical companies (ICI.
l
commerci
Meanwhtle severa
'
Celanese, Bayer, and Courtaulds) are fanning the smoking and health
fire Recognizing the 'multi-billion dollar world market for tobacco,
they are vigorously marketing their brand name substitutes among
~ '~~ .._ - ..~ ~~-.~. , ... , ... . .. ~.-..: ... :.
:~: fY.~.~.
' the cigaret manufacturers in various countries, each hoping to stake out
;~'
,{Re:. , . -i..
.
i
eee o w
Y~
a malor p
~
T
';JL~J' >,~~:a`~]l~ .i~~ -~~i
t ~)!,~i'-
~ 7~u~ ~5~ . ~ ¢X
Ql~ ie~
~'A'J!/a
T
l
~
y
!
f
h
.
~
. vY..i. .,~ r
` .:
F~
~'`
ilf
~l
ed
a
n
r
ti
ff
k
h
s
M'~
"
g
g
e e
ey a
e
ng e
ort
t
6obcitBackmg up their mar
->y~taco cgare., '-
y
.
*~- __ ~~`rL 51n';r`-~'~ .t r,'r .i `? 'y~~`e~'(~'~'*~~'~ ~,~ .'°~1~'.~'1
y~li .'~ ~'~o'~ __Y .#:~!~$X'.~t!t`~yg>. .~' ~ .. =,x M'~A~

-2-
[
(
. in mass ive research, development, and biotesting programs to generate
technical bases for their products. The possibility that their marketing
tests before giving permission for extensive marketing programs. (This
Federal authorities have required nothing more than preliminary chemical
push may be premature relative to the safety demonstration of their
products seems to be lost in the heat of competition. In Germany, for
example, where test markets of such products are under way, the
approach is in contrast with that in Britain where a Government appointed
Hunter Committee is requiring a testing program comparable to that
required of a new single drug entity).
At the same time the cigaret manufacturer is besieged from many
r
I.
I
L
F
I
!
directions. Not only is there pressure from the chemical companies
beating on the door, but there is also publicity pressure from health
authorities, anti-smoking leagues, and consumer groups to make cigaret
smoking safer. All this on top of the usual business pressures in a
highly competitive, market intensive, consumer product arena in which
each contestant is constantly wary and fearful that his competitors may
beat him to a changing market. In such a crisis atmosphere it is not
surprising to hear shouts of "DO SOMETHING!" even though that some-
thing may not be the right and sensible thing to do. It can easily happen
that the industry will be pressured into a state of panic which is not
conducive to sober contemplation and rational decision. One publication
has already described the situation as a "stampede to synthetic cigarets."
In the several years that momentum for non-tobacco substitutes in
cigarets has been gaining, very few people have objectively questioned
>::.,. . .

3
[
I
the hypothesis that such a movement will benefit the smoker. The
general attitude has been that tobacco cigarets are bad, non-tobacco
cigarets must be better. But are they?
Recently there appeared in a British editorial ("Hunter for Safe
F
t
U
I
I
I
I
I
C
Smoking," Chemistry in Britain, Vol. 10, p. 425, November 1974) a
review of non-tobacco substitute rnaterials. Serious questions re-
garding the safety and effectiveness of such materials were raised.
Cigaret manufacturers should give careful attention to these points
before exposing the smoking public to tobacco substitutes. To quote
from the editorial -
"Non-tobacco materials are meant to reduce the hazards to
the smoker; nevertheless, they present unknown and possibly
entirely new potential hazards. The smoke of the material
and of the mixtures of tobacco/non-tobacco material may
differ substantially from tobacco smoke, little knowledge of
predictive value exists. Is the "cure" going to be as bad as
the disease?"
To answer this question, medical researchers cannot test the
non-tobacco srnoking material as tobacco has been tested in man for
several hundred years under conditions of actual use. With tobacco .

-4-
t
I
II
I
~
i
I
I-
L
I
l
r
the results (such as they are) are well known and documented. What-
ever the price of smoking, it is by now generally known and accepted
by the smoker and is paid only after decades of exposure. The non-
tobacco smoke, on the other hand, must be tested like a new drug in
test animal systems. Without going into details two problems arise:
(1) No test animal system has reproduced the alleged harmful effects
of tobacco smoke in man; and (2) In order to demonstrate a less
harmful smoke the test system must be not only reproducible but also
quantifiable. It should also be relatable to health in man. The com-
plexities of bioassay procedures and cigaret smoke composition (from
either tobacco or non-tobacco materials) makes these requirements
extremely difficult to meet. ' It is thus almost impossible to ensure or
even predict by this route that smoking non-tobacco materials would be
safer for smokers. With the publicity already given, any such product
carries with it an improved health risk connotation and will be taken up
by millions of smokers. Only after.20 or 30 years would the final
judgement be possible.
Again quoting from the editorial in Chemistry in Britain:
"The real question is whether any of the non-tobacco materials
so far offer the advantages sought; for a significant effect,
levels of incorporation may have to be high so that smokers
will not accept the product ... an 80/20 or 90/10 mixture of
tobacco/cellulosic derivative, which might have been acceptable
to smokers, would offer little such gain (in health risk)."
N
O
N

5
.
I
f
r
I
i
I
I
I-
1
L
I
(
L
One of the claimed advantages of non-tobacco smoking materials
is that they deliver less tar in the smoke than tobacco. It is argued by
the smoking and hea1th advocates that more tar means greater risk to
health (biological dose-response relationship). This argument provides
the basis for generating pressures on cigaret manufacturers through
publication of FTC "Tar" or league (U. K. ) tables of tar and nicotine of
marketed cigarets to reduce the deliveries of these constituents from
their products. Let us suppose that a product contained 20 percent of a
non-tobacco material which delivered only one-fourth as much "tar" per
unit weight burned as the tobacco component. The net tar reduction
would only be 15 percent from that of an all tobacco cigaret. The smoker
could easily achieve this reduction by changing his smoking pattern
(switching to filter, taking smaller, fewer puffs, or longer butt) or by
selecting a lower delivery cigaret. Such a self imposed reduction would
avoid any unknown hazard~ in smoking a cigaret containing non-tobacco "
material.
Another supposed advantage of the non-tobacco cigaret material
is that the tar which is produced is less toxic than tobacco tar. (This
difference also appears to be true of different tobacco blends and
components. In other words, not all tars are alike in their biological
effects. This fact is ignored in the publication of a composite table
of tar and nicotine values for various cigarets). Tar toxicity comparisons

6
I
f
I
t
t
L
I
L
L
I
[
are made on the basis of equal weights of introduction into the animal
bioassay system. As a result, the lowered activity of non-tobacco
material tar offers little potential advantage to a mixed cigaret unless
the proportion of the material is very high. In fact, it has been observed
that tar from an 80/20 tobacco substitute cigaret can be just as active
biologically as the 100 percent tobacco cigaret. Some proposed non-
tobacco materials have been found to be even more active than tobacco
in animal bioassay tests and/or more active in admixtures with tobacco
than either component alone.
The hope that a tobacco/non-tobacco mixture cigaret in something
like an 80/20 or 90/10 proportion will be a safer cigaret is nothing more
than a hope. It is certainly not supported by the facts. Furthermore
the marketing of such a product in the light of recent publicity will be
nothing more than the perpetration of a fraud on the public because of '"
the irnplied~ "seal of approval." It willtake dramatic breakthroughs to
make a high level non-tobacco material cigaret acceptable to the current
generation of smokers.
O
O
As summarized in the editorial referred to before: N
N
CO
"Paradoxically, to minimize the new risks, new materials are on
likely to be offered at low incorporations, biologically almost
Ineffective, smokers (and, more important, non smokers) must
not be misled about the contribution new non-tobacco materials
will make to smoking products for somc years ahead."

I
F
I
F
i
I
I
I
I
I
I
~
(
People smoke tobacco because they like it, enjoy it, feel it does
something for them physiologically, psychologically, and/or socially.
Many attempts have been made to market cigarets made with naturally
occurring non-tobacco materials (lettuce, etc.). None have been
successful. The same can be said for the 10CF7., non-tobacco substitutes
made by the chemical companies. Apparently, the smoke from tobacco
provides a unique combination~ of naturally derived ingredients that
makes it attractive to the smoker. It would seem correct to conclude,
then, that a cigaret made with substantial proportions of non-tobacco,
chemically derived, substitute material will deprive the smoker of
many of the benefits he now perceives from smoking tobacco. Couple
this denial with the false hope that he is smoking a safer material
(which~ could in actuality be seriously hazardous to his health), the
smoker of a non-tobacco containing cigaret may in all likelihood be
the victim of the hoax of the century.
